Moderna's Earnings, Revenue Fall on Fewer Vaccine Sales

(February 24 00:41) The Wall Street Journal

Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales.

You can find the original article here